AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
Log in

NYSE:CAHCardinal Health Stock Price, Forecast & News

$54.37
+0.62 (+1.15 %)
(As of 05/28/2020 04:00 PM ET)
Add
Compare
Today's Range
$53.81
Now: $54.37
$55.29
50-Day Range
$47.02
MA: $50.22
$53.59
52-Week Range
$39.05
Now: $54.37
$60.69
Volume1.61 million shs
Average Volume2.98 million shs
Market Capitalization$15.88 billion
P/E RatioN/A
Dividend Yield3.57%
Beta0.97
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company operates through two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. It also provides services to support the development, marketing, and distribution of specialty pharmaceutical products, as well as pharmacy management, and medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products. It also distributes a range of national brand products; and medical products to patients' homes, as well as provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Read More
Cardinal Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.1Community Rank: 3.0Dividend Strength: 5.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.35 out of 5 stars


Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
CUSIP14149Y10
Phone614-757-5000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$145.53 billion
Cash Flow$8.97 per share
Book Value$4.13 per share

Profitability

Net Income$1.36 billion

Miscellaneous

Employees31,000
Market Cap$15.88 billion
Next Earnings Date8/13/2020 (Estimated)
OptionableOptionable

Receive CAH News and Ratings via Email

Sign-up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.

Cardinal Health (NYSE:CAH) Frequently Asked Questions

How has Cardinal Health's stock been impacted by COVID-19 (Coronavirus)?

Cardinal Health's stock was trading at $48.65 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CAH stock has increased by 11.8% and is now trading at $54.37. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cardinal Health?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 8 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cardinal Health.

When is Cardinal Health's next earnings date?

Cardinal Health is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Cardinal Health.

How were Cardinal Health's earnings last quarter?

Cardinal Health Inc (NYSE:CAH) released its quarterly earnings data on Monday, May, 11th. The company reported $1.62 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.43 by $0.19. The business had revenue of $39.16 billion for the quarter, compared to analyst estimates of $37.04 billion. Cardinal Health had a positive return on equity of 69.23% and a negative net margin of 2.71%. The firm's revenue was up 11.2% on a year-over-year basis. During the same quarter last year, the company earned $1.59 earnings per share. View Cardinal Health's earnings history.

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health declared a quarterly dividend on Monday, May 11th. Shareholders of record on Wednesday, July 1st will be given a dividend of $0.486 per share on Wednesday, July 15th. This represents a $1.94 annualized dividend and a dividend yield of 3.58%. The ex-dividend date of this dividend is Tuesday, June 30th. This is a boost from Cardinal Health's previous quarterly dividend of $0.48. View Cardinal Health's dividend history.

How will Cardinal Health's stock buyback program work?

Cardinal Health declared that its board has authorized a share buyback program on Thursday, November 8th 2018, which permits the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 6.4% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's management believes its stock is undervalued.

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health updated its FY20 earnings guidance on Monday, May, 11th. The company provided EPS guidance of $5.20-5.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.00.

What price target have analysts set for CAH?

11 brokers have issued 1-year price objectives for Cardinal Health's stock. Their forecasts range from $50.00 to $68.00. On average, they anticipate Cardinal Health's share price to reach $57.30 in the next twelve months. This suggests a possible upside of 5.4% from the stock's current price. View analysts' price targets for Cardinal Health.

Has Cardinal Health been receiving favorable news coverage?

Media stories about CAH stock have trended positive on Thursday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cardinal Health earned a news impact score of 3.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an impact on the stock's share price in the near term. View the latest news aboutCardinal Health.

Are investors shorting Cardinal Health?

Cardinal Health saw a decline in short interest in May. As of May 15th, there was short interest totaling 3,940,000 shares, a decline of 10.5% from the April 30th total of 4,400,000 shares. Based on an average daily volume of 3,140,000 shares, the short-interest ratio is currently 1.3 days. Approximately 1.4% of the company's stock are sold short. View Cardinal Health's Current Options Chain.

Who are some of Cardinal Health's key competitors?

What other stocks do shareholders of Cardinal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), Johnson & Johnson (JNJ), AT&T (T), Exxon Mobil (XOM), CVS Health (CVS), Gilead Sciences (GILD), Verizon Communications (VZ), Becton Dickinson and (BDX), PepsiCo (PEP) and Pfizer (PFE).

Who are Cardinal Health's key executives?

Cardinal Health's management team includes the following people:
  • Mr. Michael C. Kaufmann, CEO & Director (Age 56)
  • Mr. Jorge M. Gomez, Chief Financial Officer (Age 51)
  • Mr. Jon L. Giacomin, Chief Exec. Officer of Medical Segment (Age 54)
  • Mr. Stuart G. Laws, Sr. VP & Chief Accounting Officer (Age 56)
  • Mr. Brian S. Rice, Chief Information Officer, Exec. VP & Customer Support Services (Age 56)

What is Cardinal Health's stock symbol?

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Who are Cardinal Health's major shareholders?

Cardinal Health's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.89%), State Street Corp (6.85%), Bank of New York Mellon Corp (2.36%), Geode Capital Management LLC (1.72%), American International Group Inc. (1.66%) and Invesco Ltd. (1.59%). Company insiders that own Cardinal Health stock include Jon L Giacomin and Stuart G Laws. View institutional ownership trends for Cardinal Health.

Which major investors are selling Cardinal Health stock?

CAH stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Franklin Resources Inc., State Street Corp, APG Asset Management N.V., Bank of New York Mellon Corp, Pzena Investment Management LLC, American International Group Inc., and First Trust Advisors LP. View insider buying and selling activity for Cardinal Health.

Which major investors are buying Cardinal Health stock?

CAH stock was purchased by a variety of institutional investors in the last quarter, including Prudential PLC, AJO LP, Miller Howard Investments Inc. NY, Alyeska Investment Group L.P., BlackRock Inc., Schroder Investment Management Group, Sumitomo Mitsui Trust Holdings Inc., and Robeco Institutional Asset Management B.V.. View insider buying and selling activity for Cardinal Health.

How do I buy shares of Cardinal Health?

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cardinal Health's stock price today?

One share of CAH stock can currently be purchased for approximately $54.37.

How big of a company is Cardinal Health?

Cardinal Health has a market capitalization of $15.88 billion and generates $145.53 billion in revenue each year. The company earns $1.36 billion in net income (profit) each year or $5.28 on an earnings per share basis. Cardinal Health employs 31,000 workers across the globe.

What is Cardinal Health's official website?

The official website for Cardinal Health is www.cardinalhealth.com.

How can I contact Cardinal Health?

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]

This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.